“Safety and Efficacy of Tacrolimus Ointment 0.03 % as a Steroid-Sparing Regimen in Patients with Severe or Refractory Vernal Keratoconjunctivitis (VKC): A study from Quetta, Balochistan” (2026) Journal of Fatima Jinnah Medical University, 20(2), pp. 99–104. doi:10.37018/ONBQ9330.